NDC Pharmacologic Class N0000175624 mTOR Inhibitors [MoA]

NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Product Type
0008-1030	Rapamune	Sirolimus	Solution	Oral	Wyeth Pharmaceuticals Llc, A Subsidiary Of Pfizer Inc.	Human Prescription Drug
0008-1040	Rapamune	Sirolimus	Tablet, Sugar Coated	Oral	Wyeth Pharmaceuticals Llc, A Subsidiary Of Pfizer Inc.	Human Prescription Drug
0008-1041	Rapamune	Sirolimus	Tablet, Sugar Coated	Oral	Wyeth Pharmaceuticals Llc, A Subsidiary Of Pfizer Inc.	Human Prescription Drug
0008-1042	Rapamune	Sirolimus	Tablet, Sugar Coated	Oral	Wyeth Pharmaceuticals Llc, A Subsidiary Of Pfizer Inc.	Human Prescription Drug
0054-0470	Everolimus	Everolimus	Tablet	Oral	Hikma Pharmaceuticals Usa Inc.	Human Prescription Drug
0054-0471	Everolimus	Everolimus	Tablet	Oral	Hikma Pharmaceuticals Usa Inc.	Human Prescription Drug
0054-0472	Everolimus	Everolimus	Tablet	Oral	Hikma Pharmaceuticals Usa Inc.	Human Prescription Drug
0078-0414	Zortress	Everolimus	Tablet	Oral	Novartis Pharmaceuticals Corporation	Human Prescription Drug
0078-0415	Zortress	Everolimus	Tablet	Oral	Novartis Pharmaceuticals Corporation	Human Prescription Drug
0078-0417	Zortress	Everolimus	Tablet	Oral	Novartis Pharmaceuticals Corporation	Human Prescription Drug
0078-0422	Zortress	Everolimus	Tablet	Oral	Novartis Pharmaceuticals Corporation	Human Prescription Drug
0078-0566	Afinitor	Everolimus	Tablet	Oral	Novartis Pharmaceuticals Corporation	Human Prescription Drug
0078-0567	Afinitor	Everolimus	Tablet	Oral	Novartis Pharmaceuticals Corporation	Human Prescription Drug
0078-0594	Afinitor	Everolimus	Tablet	Oral	Novartis Pharmaceuticals Corporation	Human Prescription Drug
0078-0620	Afinitor	Everolimus	Tablet	Oral	Novartis Pharmaceuticals Corporation	Human Prescription Drug
0078-0626	Afinitor Disperz	Everolimus	Tablet, For Suspension	Oral	Novartis Pharmaceuticals Corporation	Human Prescription Drug
0078-0627	Afinitor Disperz	Everolimus	Tablet, For Suspension	Oral	Novartis Pharmaceuticals Corporation	Human Prescription Drug
0078-0628	Afinitor Disperz	Everolimus	Tablet, For Suspension	Oral	Novartis Pharmaceuticals Corporation	Human Prescription Drug
49884-119	Everolimus	Everolimus	Tablet	Oral	Par Pharmaceutical, Inc.	Human Prescription Drug
49884-125	Everolimus	Everolimus	Tablet	Oral	Par Pharmaceutical, Inc.	Human Prescription Drug
49884-127	Everolimus	Everolimus	Tablet	Oral	Par Pharmaceutical, Inc.	Human Prescription Drug
50268-718	Sirolimus	Sirolimus	Tablet	Oral	Avpak	Human Prescription Drug
55111-653	Sirolimus	Sirolimus	Tablet	Oral	Dr. Reddy's Laboratories Limited	Human Prescription Drug
55111-654	Sirolimus	Sirolimus	Tablet	Oral	Dr. Reddy's Laboratories Limited	Human Prescription Drug
59762-1001	Sirolimus	Sirolimus	Tablet, Sugar Coated	Oral	Greenstone Llc	Human Prescription Drug
59762-1002	Sirolimus	Sirolimus	Tablet, Sugar Coated	Oral	Greenstone Llc	Human Prescription Drug
59762-1003	Sirolimus	Sirolimus	Tablet, Sugar Coated	Oral	Greenstone Llc	Human Prescription Drug
59762-1205	Sirolimus	Sirolimus	Solution	Oral	Greenstone Llc	Human Prescription Drug
60505-6197	Sirolimus	Sirolimus	Solution	Oral	Apotex Corp	Human Prescription Drug
65841-771	Sirolimus	Sirolimus	Tablet, Film Coated	Oral	Cadila Healthcare Limited	Human Prescription Drug
66689-347	Sirolimus	Sirolimus	Solution	Oral	Vistapharm, Inc.	Human Prescription Drug
68084-915	Sirolimus	Sirolimus	Tablet	Oral	American Health Packaging	Human Prescription Drug
68382-520	Sirolimus	Sirolimus	Tablet, Film Coated	Oral	Zydus Pharmaceuticals (usa) Inc.	Human Prescription Drug
69238-1594	Sirolimus	Sirolimus	Solution	Oral	Amneal Pharmaceuticals Ny Llc	Human Prescription Drug

There are 34 NDC products with the pharmacologic class mTOR Inhibitors [MoA].